To test this hypothesis we measured filarial antigen, CIC, LPS Binding Protein (LBP) and components of the complement cascade in plasma before and after treatment, and we studied host transcriptional responses and cytokine profiles in LF-infected individuals who experienced AEs after treatment. This evidence concerns the gene LBP and Lassa fever.